Thoracic radiotherapy variables: Influence on local control in small cell lung cancer limited disease

International Journal of Radiation Oncology, Biology, Physics

Volumn 19, Issue 6, 1990, Pages 1473-1479

  Turrisi III, Andrew T ^a   Glover, Donna J ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b PENN PRESBYTERIAN MEDICAL CENTER   (United States)

Author keywords

Combined modality therapy; Concurrent chemoradiotherapy; Limited small cell lung cancer; Twice daily radiotherapy

Indexed keywords

CISPLATIN; ETOPOSIDE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG NON SMALL CELL CANCER; MALE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SMALL CELL; CISPLATIN; COMBINED MODALITY THERAPY; ETOPOSIDE; HUMAN; LUNG NEOPLASMS; RADIOTHERAPY DOSAGE; SURVIVAL RATE;

EID: 0025652727     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(90)90360-V     Document Type: Article

References (17)

1. Alternating radiotherapy and chemotherapy schedules in small cell lung cancer, limited disease
2. The role of surgery in the management of selected patients with small-cell carcinoma of the lung
3. Chemotherapy alone or chemotherapy with chest radiation therapy in limited stage small cell lung cancer
4. In vitro radiation and chemotherapy sensitivity of established cell lines of human small cell lung cancer and its large cell morphological variants
5. Small cell lung cancer: Analysis of treatment fractors contributing to prolonged survival
6. Importance of radiation dose in achieving improved loco-regional tumor control in limited stage small-cell lung carcinoma: an update
7. Small cell carcinoma of the lung
8. Cisplatin plus etoposide consolidation following cyclophosphamide, doxorubicin, and vincristine in limited small-cell lung cancer
9. Limited (LTD) stage small cell lung cancer (SCLS) treated with concurrent etoposide/cisplatin (VP-PLAT) plus Bid chest radiotherapy (RT)
10. Concurrent chemotherapy/radiotherapy for limited small cell lung carcinoma
11. Phase II trial of extended indications for resection in small cell carcinoma of the lung
12. Randomized trial of radiotherapy to the thorax in limited small cell carcinoma of the lung treated with multiagent chemotherapy and elective brain irradiation: a preliminary report
13. Chemotherapy with or without radiation therapy in limited small cell carcinoma of the lung
14. Increased survival with high-dose multifield radiotherapy and intensive chemotherapy in limited small cell carcinoma of the lung
15. Dichlorodiammine Platinum (11) and VP-16-213: an active induction regimen for small cell carcinoma of the lung
16. A preliminary report: concurrent twice-daily radiotherapy plus platinumetoposide chemotherapy for limited small cell lung cancer
17. Prophylactic Cranial Irradiation (PCI) after chemotherapy as part of a combined modality Platinum (DDP)-Etoposide (VP-16) and twice-daily chest radiotherapy (Bid-TRT) for limited small cell lung cancer (LSCLC)